Velan Capital Investment Management »

Esperion Therapeutics shares owned by Velan Capital Investment Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Velan Capital Investment Management from 13F filings

Historical chart of Velan Capital Investment Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Velan Capital Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.5M 1.2M 3.70

More positions owned by Velan Capital Investment Management

Praxis Precision Medicines I Com New (PRAX)
Cidara Therapeutics Com New (CDTX)
Protara Therapeutics Com Stk (TARA)
Heron Therapeutics (HRTX)
Maplight Therapeutics (MPLT)
Abivax Sa Sponsored Ads (ABVX)
Evommune Com Shs (EVMN)
Mineralys Therapeutics (MLYS)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Jasper Therapeutics Com New (JSPR)
Avalo Therapeutics Com New (AVTX)
Esperion Therapeutics (ESPR)
Verrica Pharmaceuticals Com Shs (VRCA)
Inspiremd (NSPR)
Rapt Therapeutics Com New (RAPT)

View all positions for Velan Capital Investment Management

Top funds holding Esperion Therapeutics

Vanguard Group
BlackRock
Two Seas Capital
Daniel D. Thurber
State Street Corporation
Geode Capital Management
Marshall Wace
PenderFund Capital Management
AIGH Capital Management
Eversept Partners
Nuveen
Royce & Associates
Goldman Sachs Group
Two Sigma Investments
Renaissance Technologies

View all funds holding Esperion Therapeutics